BlackRock’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-431,406
| Closed | -$1.15M | – | 5350 |
|
|
2024
Q1 | $1.15M | Sell |
431,406
-155,282
| -26% | -$413K | ﹤0.01% | 4107 |
|
|
2023
Q4 | $1.39M | Sell |
586,688
-154,662
| -21% | -$367K | ﹤0.01% | 4083 |
|
|
2023
Q3 | $1.04M | Buy |
741,350
+18,348
| +3% | +$25.7K | ﹤0.01% | 4168 |
|
|
2023
Q2 | $2.19M | Sell |
723,002
-1,554,107
| -68% | -$4.71M | ﹤0.01% | 3935 |
|
|
2023
Q1 | $14.2M | Sell |
2,277,109
-58,709
| -3% | -$367K | ﹤0.01% | 3075 |
|
|
2022
Q4 | $14.2M | Buy |
2,335,818
+59,002
| +3% | +$360K | ﹤0.01% | 3147 |
|
|
2022
Q3 | $27.2M | Sell |
2,276,816
-22,728
| -1% | -$272K | ﹤0.01% | 2825 |
|
|
2022
Q2 | $29M | Buy |
2,299,544
+244,320
| +12% | +$3.08M | ﹤0.01% | 2824 |
|
|
2022
Q1 | $23.1M | Buy |
2,055,224
+8,189
| +0.4% | +$92.2K | ﹤0.01% | 3016 |
|
|
2021
Q4 | $36.3M | Buy |
2,047,035
+172,674
| +9% | +$3.06M | ﹤0.01% | 2848 |
|
|
2021
Q3 | $43.1M | Buy |
1,874,361
+600,832
| +47% | +$13.8M | ﹤0.01% | 2732 |
|
|
2021
Q2 | $29.6M | Buy |
1,273,529
+63,331
| +5% | +$1.47M | ﹤0.01% | 3015 |
|
|
2021
Q1 | $37.7M | Buy |
1,210,198
+900,654
| +291% | +$28.1M | ﹤0.01% | 2766 |
|
|
2020
Q4 | $12.3M | Buy |
+309,544
| New | +$12.3M | ﹤0.01% | 3199 |
|